Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s

European Journal of Cancer

Volumn 44, Issue 10, 2008, Pages 1345-1389

  Karim Kos, Henrike E ^a   de Vries, Esther ^a   Soerjomataram, Isabelle ^a   Lemmens, Valery ^a,b   Siesling, Sabine ^c   Coebergh, Jan Willem W ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Eindhoven Cancer Registry   (Netherlands)

^c Integraal Kankercentrum Stedendriehoek Twente   (Netherlands)

Author keywords

Cancer registry; Europe; Incidence; Mortality; Neoplasm; Survival; Trends

Indexed keywords

ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; COLORECTAL CANCER; EPIDEMIC; ESOPHAGUS CANCER; EUROPE; GEOGRAPHIC DISTRIBUTION; HODGKIN DISEASE; HUMAN; KIDNEY CANCER; LARYNX CANCER; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MOUTH CANCER; OBESITY; OVARY CANCER; PANCREAS CANCER; PHARYNX CANCER; POPULATION RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; SMOKING; STOMACH CANCER; TESTIS CANCER; TOBACCO; UTERINE CERVIX CANCER; UTERUS CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; EUROPE; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; PREGNANCY; REGISTRIES;

EID: 44649159153     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.12.015     Document Type: Article

References (117)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 2 (2005) 74-108
2. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., and Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18 3 (2007) 581-592
3. Verdecchia A., Francisci S., Brenner H., Gatta G., Micheli A., Mangone L., et al. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol (2007)
4. Welch H.G., Schwartz L.M., and Woloshin S. Are increasing 5-year survival rates evidence of success against cancer?. Jama 283 22 (2000) 2975-2978
5. Sant M., Francisci S., Capocaccia R., Verdecchia A., Allemani C., and Berrino F. Should we use incidence, survival or mortality to assess breast cancer trends in European women?. Nat Clin Pract Oncol 3 5 (2006) 228-229
6. Coleman M.P., Gatta G., Verdecchia A., Esteve J., Sant M., Storm H., et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 14 Suppl 5 (2003) v128-v149
7. EUROCARE-3. http://www.eurocare.it/CDEu3/Index.htm "Survival of cancer patients in Europe: The EUROCARE-3 study" (accessed October 2007).
8. Sant M., Aareleid T., Berrino F., Bielska Lasota M., Carli P.M., Faivre J., et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol 14 Suppl 5 (2003) V61-V118
9. Berrino F., De Angelis R., Sant M., Rosso S., Lasota M.B., Coebergh J.W., et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 8 9 (2007) 773-783
10. Chin D., Boyle G.M., Porceddu S., Theile D.R., Parsons P.G., and Coman W.B. Head and neck cancer: past, present and future. Expert Rev Anticancer Ther 6 7 (2006) 1111-1118
11. Vizcaino A.P., Moreno V., Lambert R., and Parkin D.M. Time trends incidence of both major histologic types of esophageal carcinomas in selected countries, 1973-1995. Int J Cancer 99 6 (2002) 860-868
12. Crane L.M., Schaapveld M., Visser O., Louwman M.W., Plukker J.T., and van Dam G.M. Oesophageal cancer in The Netherlands: Increasing incidence and mortality but improving survival. Eur J Cancer 43 9 (2007) 1445-1451
13. Levi F., Te V.C., Randimbison L., and La Vecchia C. Trends in survival for both histologic types of esophageal cancer in Switzerland. Int J Cancer 108 4 (2004) 638-639
14. van Lanschot J.J., Rutten H.J., Boom R.P., and Gouma D.J. [Importance of regional surgery networks]. Ned Tijdschr Geneeskd 144 24 (2000) 1148-1152
15. Black R.J., Bray F., Ferlay J., and Parkin D.M. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer 33 7 (1997) 1075-1107
16. Prinz C., Schwendy S., and Voland P. H pylori and gastric cancer: shifting the global burden. World J Gastroenterol 12 34 (2006) 5458-5464
17. Forman D., and Burley V.J. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 20 4 (2006) 633-649
18. Remontet L., Esteve J., Bouvier A.M., Grosclaude P., Launoy G., Menegoz F., et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 51 1 Pt 1 (2003) 3-30
19. Verdecchia A., Corazziari I., Gatta G., Lisi D., Faivre J., Forman D., et al. Explaining gastric cancer survival differences among European countries. Int J Cancer 109 5 (2004) 737-741
20. Hartgrink H.H., Bonenkamp H.J., and van de Velde C.J. Influence of surgery on outcomes in gastric cancer. Surg Oncol Clin N Am 9 1 (2000) 97-117 vii-viii
21. Bergstrom A., Pisani P., Tenet V., Wolk A., and Adami H.O. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 91 3 (2001) 421-430
22. Lopez-Abente G., Pollan M., Vergara A., Moreno C., Moreo P., Ardanaz E., et al. Age-period-cohort modeling of colorectal cancer incidence and mortality in Spain. Cancer Epidemiol Biomarkers Prev 6 12 (1997) 999-1005
23. Pischon T., Lahmann P.H., Boeing H., Tjonneland A., Halkjaer J., Overvad K., et al. Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 118 3 (2006) 728-738
24. Rougier P., and Mitry E. Epidemiology, treatment and chemoprevention in colorectal cancer. Ann Oncol 14 Suppl 2 (2003) ii3-ii5
25. Faivre-Finn C., Bouvier-Benhamiche A.M., Phelip J.M., Manfredi S., Dancourt V., and Faivre J. Colon cancer in France: evidence for improvement in management and survival. Gut 51 1 (2002) 60-64
26. Chessin D.B., and Guillem J.G. Surgical issues in rectal cancer: a 2004 update. Clin Colorectal Cancer 4 4 (2004) 233-240
27. Engholm G., Kejs A.M., Brewster D.H., Gaard M., Holmberg L., Hartley R., et al. Colorectal cancer survival in the Nordic countries and the United Kingdom: Excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000. Int J Cancer 121 5 (2007) 1115-1122
28. Levi F., Lucchini F., Negri E., and La Vecchia C. Pancreatic cancer mortality in Europe: the leveling of an epidemic. Pancreas 27 2 (2003) 139-142
29. Coughlin S.S., Calle E.E., Patel A.V., and Thun M.J. Predictors of pancreatic cancer mortality among a large cohort of United States adults. Cancer Causes Control 11 10 (2000) 915-923
30. Qiu D., Kurosawa M., Lin Y., Inaba Y., Matsuba T., Kikuchi S., et al. Overview of the epidemiology of pancreatic cancer focusing on the JACC Study. J Epidemiol 15 Suppl 2 (2005) S157-S167
31. Giovannucci E., and Michaud D. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology 132 6 (2007) 2208-2225
32. Lo A.C., Soliman A.S., El-Ghawalby N., Abdel-Wahab M., Fathy O., Khaled H.M., et al. Lifestyle, occupational, and reproductive factors in relation to pancreatic cancer risk. Pancreas 35 2 (2007) 120-129
33. Michaud D.S. Epidemiology of pancreatic cancer. Minerva Chir 59 2 (2004) 99-111
34. Higginson J., Muir C.S., and Muñoz N. Human cancer: epidemiology and environmental causes (1992), Cambridge University Press, Cambridge
35. Talamini R., Bosetti C., La Vecchia C., Dal Maso L., Levi F., Bidoli E., et al. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control 13 10 (2002) 957-964
36. Tuyns A.J., Esteve J., Raymond L., Berrino F., Benhamou E., Blanchet F., et al. Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). Int J Cancer 41 4 (1988) 483-491
37. In: Schottenfeld D., and Fraumeni J.F. (Eds). Cancer epidemiology and prevention. 3rd ed. (2006), Oxford University Press, New York, USA
38. Bosetti C., Levi F., Lucchini F., Negri E., and La Vecchia C. Lung cancer mortality in European women: recent trends and perspectives. Ann Oncol 16 10 (2005) 1597-1604
39. de Vries E., Bray F., Coebergh J.W.W., Parkin D.M., and ENCR. Changing Epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality, but recent stabilisations in Western Europe and decreases in Scandinavia. Int J Cancer 107 1 (2003) 119-126
40. Stratigos A., Nikolaou V., Kedicoglou S., Antoniou C., Stefanaki I., Haidemenos G., et al. Melanoma/skin cancer screening in a Mediterranean country: results of the Euromelanoma Screening Day Campaign in Greece. J Eur Acad Dermatol Venereol 21 1 (2007) 56-62
41. de Vries E., Houterman S., Janssen-Heijnen M., Nijsten T., van de Schans S., Eggermont A., et al. Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands. Ann Oncol 18 (2007) 1110-1116
42. International Agency for Research on Cancer. IARC Handbooks of Cancer Prevention. Volume 7: Breast cancer screening. Lyon: IARCPress; 2002.
43. Botha J.L., Bray F., Sankila R., and Parkin D.M. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer 39 12 (2003) 1718-1729
44. Eurostat. A statistical view of the life of women and men in the EU25. Eurostat News Release 29 (2006)
45. Soerjomataram I., Pukkala E., Brenner H., and Coebergh J.W. On the avoidability of breast cancer in industrialized societies: older mean age at first birth as an indicator of excess breast cancer risk. Breast Cancer Res Treat (2007)
46. Katalinic A., and Rawal R. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat (2007)
47. Glass A.G., Lacey Jr. J.V., Carreon J.D., and Hoover R.N. Breast cancer ncidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst 99 15 (2007) 1152-1161
48. Bosch F.X., Lorincz A., Munoz N., Meijer C.J., and Shah K.V. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55 4 (2002) 244-265
49. Arbyn M., Autier P., and Ferlay J. Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004. Ann Oncol 18 8 (2007) 1423-1425
50. Primic-Zakelj M., and Repse-Fokter A. Cervical cancer screening: A Slovenian experience. Coll Antropol 31 Suppl 2 (2007) 23-26
51. Nygard M., Daltveit A.K., Thoresen S.O., and Nygard J.F. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study. BMC Health Serv Res 7 (2007) 10
52. Berkers L.M., van Ballegooijen M., van Kemenade F.J., Rebolj M., Essink-Bot M.L., Helmerhorst T.J., et al. [The 1996 revision of the Dutch cervical cancer screening programme: increased coverage, fewer repeat smears and less opportunistic screening]. Ned Tijdschr Geneeskd 151 23 (2007) 1288-1294
53. Bielska-Lasota M., Inghelmann R., van de Poll-Franse L., Capocaccia R., and Group E.W. Trends in cervical cancer survival in Europe, 1983-1994: a population-based study. Gynecol Oncol 105 3 (2007) 609-619
54. Bray F., Loos A.H., Oostindier M., and Weiderpass E. Geographic and temporal variations in cancer of the corpus uteri: incidence and mortality in pre- and postmenopausal women in Europe. Int J Cancer 117 1 (2005) 123-131
55. Siesling S, van der Aa MA, Coebergh JW, Pukkala E. Cancer maps of the Netherlands, 1989-2003: Time-space trends in cancer incidence in the Netherlands in 1989-2003. Int J Cancer 2007((accepted)).
56. Janssen-Heijnen MLG, Louwman MW, van de Poll-Franse LV, Coebergh JWW, Houterman S, Lemmens VEP, et al. Van meten naar weten. 50 jaar kankerregistratie. Eindhoven: Integraal kankercentrum zuid; 2005.
57. Elit L., Bondy S.J., Chen Z., and Paszat L. A tale of two time periods: ovarian cancer trends in Ontario. Curr Oncol 14 2 (2007) 57-60
58. Engelen M.J., Kos H.E., Willemse P.H., Aalders J.G., de Vries E.G., Schaapveld M., et al. Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer 106 3 (2006) 589-598
59. Jacobsen R., Moller H., Thoresen S.O., Pukkala E., Kjaer S.K., and Johansen C. Trends in testicular cancer incidence in the Nordic countries, focusing on the recent decrease in Denmark. Int J Androl 29 1 (2006) 199-204
60. Bray F., Ferlay J., Devesa S.S., McGlynn K.A., and Moller H. Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol 3 10 (2006) 532-543
61. Verhoeven R., Houterman S., Kiemeney B., Koldewijn E., and Coebergh J.W. Testicular cancer: Marked birth cohort effects on incidence and a decline in mortality in southern Netherlands since 1970. Int J Cancer (2007)
62. Moller H., and Skakkebaek N.E. Testicular cancer and cryptorchidism in relation to prenatal factors: case-control studies in Denmark. Cancer Causes Control 8 6 (1997) 904-912
63. Richiardi L., Pettersson A., and Akre O. Genetic and environmental risk factors for testicular cancer. Int J Androl 30 4 (2007) 230-241
64. Richiardi L., Akre O., Lambe M., Granath F., Montgomery S.M., and Ekbom A. Birth order, sibship size, and risk for germ-cell testicular cancer. Epidemiology 15 3 (2004) 323-329
65. Einhorn L.H. Curing metastatic testicular cancer. Proc Natl Acad Sci U S A 99 7 (2002) 4592-4595
66. Sant M., Aareleid T., Artioli M.E., Berrino F., Coebergh J.W., Colonna M., et al. Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution study. Eur J Cancer 43 3 (2007) 585-592
67. Ferlay J., Randi G., Bosetti C., Levi F., Negri E., Boyle P., et al. Declining mortality from bladder cancer in Europe. BJU Int (2007)
68. Malmstrom P.U. Why Has the Survival of Patients with Bladder Cancer Not Improved?. BJU Int (2007)
69. Adamson P., Bray F., Costantini A.S., Tao M.H., Weiderpass E., and Roman E. Time trends in the registration of Hodgkin and non-Hodgkin lymphomas in Europe. Eur J Cancer 43 2 (2007) 391-401
70. Brenner H., Coebergh J., Parkin D., Izarzugaza I., Clavel J., Arndt V., et al. Up-to-date monitoring of childhood cancer long-term survival in Europe: leukaemias and lymphomas. Ann Oncol (2007)
71. Maucort-Boulch D., Djeridane M., Roy P., Riche B., Colonna P., and Andrieu J.M. Predictive and discriminating three-risk-group prognostic scoring system for staging Hodgkin lymphomas. Cancer 109 2 (2007) 256-264
72. Soerjomataram I., de Vries E., Pukkala E., and Coebergh J.W. Excess of cancers in Europe: a study of eleven major cancers amenable to lifestyle change. Int J Cancer 120 6 (2007) 1336-1343
73. Gondos A., Holleczek B., Arndt V., Stegmaier C., Ziegler H., and Brenner H. Trends in population-based cancer survival in Germany: to what extent does progress reach older patients?. Ann Oncol 18 7 (2007) 1253-1259
74. Boyle P., Autier P., Bartelink H., Baselga J., Boffetta P., Burn J., et al. European Code Against Cancer and scientific justification: third version (2003). Ann Oncol 14 7 (2003) 973-1005
75. European Network of Cancer Registries. Eurocim version 4.0. European incidence database V2.3, ICD-10 dictionary (2001) and European mortality database V2.3 (2001) Lyon 2001.
76. Engholm G, Storm HH, Ferlay J, Christensen N, Bray F, Ólafsdóttir E, et al. http://www-dep.iarc.fr/nordcan.htm "The NORDCAN database. Association of the Nordic Cancer Registries (accessed October 2007).
77. Finnish Cancer Registry. http://www.cancerregistry.fi/eng/statistics/9-37.html "Newest survival rates" (accessed October 2007).
78. Cancer Registry of Norway. Cancer in Norway 2005: Cancer incidence, mortality, survival and prevalence in Norway (2006), Cancer registry of Norway, Oslo
79. Statistics - Health and Diseases. Cancer incidence in Sweden 2005 (2007), The National Board of Health and Welfare, Centre for Epidemiology, Stockholm
80. National Cancer Registry Ireland. http://www.ncri.ie/data.cgi/index.shtml (accessed September 2007).
81. Walsh P.M., and Comber H. Patterns of care and survival of cancer patients in Ireland 1994 to 2001: time-trends and regional variation for breast, colorectal, lung and prostate cancer (2006), National Cancer Registry, Cork
82. Central Statistics Office Ireland. Report on Vital Statistics 2004. Cork: Central Statistics Office; 2006.
83. Central Statistics Office Ireland. Report on Vital Statistics 2003. Cork: Central Statistics Office; 2005.
84. Office for National Statistics. http://www.statistics.gov.uk/statbase/Product.asp?vlnk=8843 "Cancer Statistics: Registration Series MB1" (accessed July 2007).
85. WHO Health Organization Statistical Information System. WHO mortality database (2006), World Health Organization, Geneva
86. Cancer Research UK. http://info.cancerresearchuk.org/cancerstats/survival/siteandsex/ Cancer survival statistics by cancer site" (accessed October 2007).
87. Office for National Statistics. http://www.statistics.gov.uk/statbase/Product.asp?vlnk=618 "Mortality Statistics: Cause (Series DH2)" (accessed August 2007).
88. Northern Ireland Cancer Registry. http://www.qub.ac.uk/research-centres/nicr/Data/OnlineStatistics/ Online Statistics" (accessed October 2007).
89. Northern Ireland Cancer Registry. Survival of cancer patients in Northern Ireland:1993-2004 (2007), Northern Ireland Cancer Registry, Belfast
90. Information Services Directorate. http://www.isdscotland.org/isd/cancer-statistics.jsp?pContentID=183&p_applic=CCC&p_service=Content.show& "Cancer Statistics (accessed October 2007).
91. Institut für klinische Epidemiologie der TILAK http://www.iet.at/index.php?id=3085 "Publikationen" (accessed July 2007).
92. French Institute for Public Health Surveillance. http://www.invs.sante.fr/estimations_cancer/index.htm "Estimation of cancer incidence and mortality in France 1978-2000" (accessed October 2007).
93. FRANCIM. Survie des patients atteints de cancer en France (2007), FRANCIM, Paris
94. Epidemiologisches Krebsregister Saarland. http://www.krebsregister.saarland.de/datenbank/datenbank.html (accessed October 2007).
95. Netherlands Cancer Registry. http://www.ikcnet.nl/cijfers/index.php?taal=en "NCR data" (accessed September 2007).
96. Comprehensive Cancer Centre Amsterdam. http://www.ikcnet.nl/page.php?nav_id=160®io_id=117&id=1735 Overlevingscijfers IKA-regio" (accessed October 2007).
97. Comprehensive Cancer Centre South. http://ikz.maatoplossing.nl/ "Data of the Eindhoven Cancer Registry (accessed October 2007).
98. Swiss Association of Cancer Registries. Cancer in Switzerland: Volume 1 - Statistics of Incidence 1985-2003. Geneva; 2006.
99. Registre Genevois des Tumeurs. http://asrt.ch/RGT/ "La publication en bref" (accessed October 2007).
100. Modena Cancer Registry. http://www.rtm.unimo.it/eng/pubblicazioni.html "Publications" (accessed July 2007).
101. Federico M. Cancer in Modena 1988-2005 (2007), Modena Cancer Registry, Modena
102. AIRTUM Working Group. Italian cancer figure, report 2007: Survival. Epidemiologia & Prevenzione 31 suppl 11 (2007) 1-96
103. Malta National Cancer Registry, Department of Health and Information. http://www.sahha.gov.mt/pages.aspx?page=44 "Information and Statistics" (accessed August 2007).
104. Cancer incidence in Slovenia 2001. Ljubljana: Institute of Oncology, Cancer Registry of Slovenia; 2004.
105. Cancer incidence in Slovenia 2002. Ljubljana Institute of Oncology, Cancer Registry of Slovenia; 2005.
106. Cancer incidence in Slovenia 2003. Ljubljana: Institute of Oncology, Cancer Registry of Slovenia; 2006.
107. Dušek L, Muži{dotless}́k J, Kubásek M, Kopti{dotless}́ková J, Žaloudi{dotless}́k J, Vyzula R. http://www.svod.cz/?sec=analyzy&lang=en "Epidemiology of malignant tumors - analyses. (accessed October 2007).
108. Cancer incidence 2004 in the Czech Republic. Prague: National Oncologic Registry; 2007.
109. Lithuanian Cancer Registry. http://www.is.lt/cancer_reg/ (accessed October 2007).
110. National Cancer Registry Poland. http://85.128.14.124/krn/english/index.asp "Reports based on data of National Cancer Registry" (accessed October 2007).
111. Oberaigner W, Mühlböck H, Harrasser L. Mammakarzinome in Tirol. Innsbruck: Institut für klinische epidemiologie der TILAK GmbH; 2003.
112. Oberaigner W, Mühlböck H, Harrasser L. Magenkarzinome in Tirol. Innsbruck: Institut für klinische epidemiologie der TILAK GmbH; 2004.
113. Oberaigner W, Mühlböck H, Harrasser L. Kolorektalen karzinome in Tirol. Innsbruck: Institut für klinische epidemiologie der TILAK GmbH; 2003.
114. Oberaigner W, Mühlböck H, Harrasser L. Lungenkarzinome in Tirol. Innsbruck: Institut für klinische epidemiologie der TILAK GmbH; 2003.
115. Oberaigner W, Mühlböck H, Harrasser L. Prostatakarzinome in Tirol. Innsbruck: Institut für klinische epidemiologie der TILAK GmbH; 2003.
116. Swiss Association of Cancer Registries. Cancer in Switzerland: Volume 2 - Statistics of Mortality 1985-2003. Geneva; 2006.
117. http://www.eurocare.it/CDEu3/Index.htm. Survival of cancer patients in Europe: The EUROCARE-3 study. In: EUROCARE-3.